Ontology highlight
ABSTRACT: Purpose
Glutaric aciduria type 1 (GA1), a rare inherited neurometabolic disorder, results in a complex movement disorder (MD) with predominant dystonia if untreated. Implementation into newborn screening (NBS) programs and adherence to recommended therapy are thought to improve the neurological outcome.Methods
Systematic literature search for articles published from 2000 to 2019 was performed using the PRISMA protocol. Studies reporting on more than one individual identified by NBS were included. We investigated effects of interventional and noninterventional variables on neurological outcome.Results
Fifteen publications reporting on 647 GA1 patients were included. In the NBS group (n?=?261 patients), 195 patients remained asymptomatic (74.7%), while 66 patients (25.3%) developed a MD. Compared with the NBS group, a much higher proportion of patients (349/386; 90.4%; p?ConclusionsThis meta-analysis demonstrates that NBS programs for GA1 have an overall positive effect on the neurological outcome of affected individuals but their success critically depends on the quality of therapy.
SUBMITTER: Boy N
PROVIDER: S-EPMC7790745 | biostudies-literature | 2021 Jan
REPOSITORIES: biostudies-literature
Boy Nikolas N Mengler Katharina K Heringer-Seifert Jana J Hoffmann Georg F GF Garbade Sven F SF Kölker Stefan S
Genetics in medicine : official journal of the American College of Medical Genetics 20200928 1
<h4>Purpose</h4>Glutaric aciduria type 1 (GA1), a rare inherited neurometabolic disorder, results in a complex movement disorder (MD) with predominant dystonia if untreated. Implementation into newborn screening (NBS) programs and adherence to recommended therapy are thought to improve the neurological outcome.<h4>Methods</h4>Systematic literature search for articles published from 2000 to 2019 was performed using the PRISMA protocol. Studies reporting on more than one individual identified by N ...[more]